HDAC6 regulates LPS-tolerance in astrocytes

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Beurel, Eléonore ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; HISTONE DEACETYLASE; HISTONE DEACETYLASE 6; LIPOPOLYSACCHARIDE; TUBACIN; TUBULIN; DNA (CYTOSINE 5) METHYLTRANSFERASE; HDAC6 PROTEIN, MOUSE; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 6; LITHIUM;

ANIMAL CELL; ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEACETYLATION; DEGENERATIVE DISEASE; ENZYME ACTIVITY; ENZYME INHIBITION; HOST; INFLAMMATION; INFLAMMATORY TOLERANCE; MENTAL DISEASE; MOUSE; NONHUMAN; PHYSICAL TOLERANCE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PROTEIN BINDING;

ANIMALS; ASTROCYTES; DNA-CYTOSINE METHYLASES; GLYCOGEN SYNTHASE KINASE 3; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LITHIUM; MICE; MICE, INBRED C57BL; PROTEIN BINDING;

EID: 80053933074     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025804     Document Type: Article

References (42)

1. Schneider DS, Ayres JS, (2008) Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat Rev Immunol 8: 889-895.
2. Ziegler-Heitbrock HW, (1995) Molecular mechanism in tolerance to lipopolysaccharide. J Inflamm 45: 13-26.
3. Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, et al. (1993) Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A 90: 10061-10065.
4. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW, (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9: 46-56.
5. Miller AH, Maletic V, Raison CL, (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65: 732-741.
6. Rivest S, (2009) Regulation of innate immune responses in the brain. Nat Rev Immunol 9: 429-439.
7. Zipp F, Aktas O, (2006) The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci 29: 518-527.
8. Craft JM, Watterson DM, Van Eldik LJ, (2005) Neuroinflammation: a potential therapeutic target. Expert Opin Ther Targets 9: 887-900.
9. Kim SU, de Vellis J, (2005) Microglia in health and disease. J Neurosci Res 81: 302-313.
10. Beurel E, Jope RS, (2010) Glycogen synthase kinase-3 regulates inflammatory tolerance in astrocytes. Neuroscience 169: 1063-1070.
11. Foster SL, Hargreaves DC, Medzhitov R, (2007) Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978.
12. Verdin E, Dequiedt F, Kasler HG, (2003) Class II histone deacetylases: versatile regulators. Trends Genet 19: 286-293.
13. Li Y, Zhang X, Polakiewicz RD, Yao TP, Comb MJ, (2008) HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization. J Biol Chem 283: 12686-12690.
14. Ding H, Dolan PJ, Johnson GVW, (2008) Histone deacetylase 6 interacts with the microtubule-associated protein tau. J Neurochem 106: 2119-2130.
15. McCarthy KD, de Vellis J, (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85: 890-902.
16. Beurel E, Jope RS, (2009) Glycogen synthase kinase-3 promotes the synergistic action of interferon-gamma on lipopolysaccharide-induced IL-6 production in RAW264.7 cells. Cell Signal 21: 978-985.
17. Beurel E, Jope RS, (2008) Differential regulation of STAT family members by glycogen synthase kinase-3. J Biol Chem 283: 21934-21944.
18. Klein PS, Melton DA, (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93: 8455-8459.
19. Stambolic V, Ruel L, Woodgett JR, (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6: 1664-1668.
20. Wagman AS, Johnson KW, Bussiere DE, (2004) Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes. Curr Pharm Des 10: 1105-1137.
21. Martinez A, Alonso M, Castro A, Perez C, Moreno FJ, (2002) First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease. J Med Chem 45: 1292-1299.
22. Chen PS, Wang CC, Bortner CD, Peng GS, Wu X, et al. (2007) Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity. Neuroscience 149: 203-212.
23. Gurvich N, Tsygankova OM, Meinkoth JL, Klein PS, (2004) Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res 64: 1079-1086.
24. Haggarty SJ, Koeller KM, Wong JC, Grozinger CM, Schreiber SL, (2003) Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci U S A 100: 4389-4394.
25. Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, et al. (2002) HDAC6 is a microtubule-associated deacetylase. Nature 417: 455-458.
26. Sanchez JF, Sniderhan LF, Williamson AL, Fan S, Chakraborty-Sett S, et al. (2003) Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling. Mol Cell Biol 23: 4649-4662.
27. Doble BW, Woodgett JR, (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116: 1175-1186.
28. McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, et al. (2005) Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J 24: 1571-1583.
29. Ayala A, Knotts JB, Ertel W, Perrin MM, Morrison MH, et al. (1993) Role of interleukin 6 and transforming growth factor-beta in the induction of depressed splenocyte responses following sepsis. Arch Surg 128: 89-94; discussion 94-85.
30. Brandtzaeg P, Osnes L, Ovstebo R, Joo GB, Westvik AB, et al. (1996) Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes. J Exp Med 184: 51-60.
31. Chen W, Frank ME, Jin W, Wahl SM, (2001) TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 14: 715-725.
32. Marie C, Fitting C, Muret J, Payen D, Cavaillon JM, (2000) Interleukin 8 production in whole blood assays: Is interleukin 10 responsible for the downregulation observed in sepsis? Cytokine 12: 55-61.
33. Miller-Graziano CL, Szabo G, Griffey K, Mehta B, Kodys K, et al. (1991) Role of elevated monocyte transforming growth factor beta (TGF beta) production in posttrauma immunosuppression. J Clin Immunol 11: 95-102.
34. Cavaillon JM, Adib-Conquy M, (2006) Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care 10: 233-240.
35. Brint EK, Xu D, Liu H, Dunne A, McKenzie AN, et al. (2004) ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol 5: 373-379.
36. Blackwell TS, Blackwell TR, Christman JW, (1997) Induction of endotoxin tolerance depletes nuclear factor-kappaB and suppresses its activation in rat alveolar macrophages. J Leukoc Biol 62: 885-891.
37. Ziegler-Heitbrock HW, Wedel A, Schraut W, Strobel M, Wendelgass P, et al. (1994) Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. J Biol Chem 269: 17001-17004.
38. Villagra A, Cheng F, Wang HW, Suarez I, Glozak M, et al. (2009) The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance. Nat Immunol 10: 92-100.
39. Into T, Inomata M, Niida S, Murakami Y, Shibata K, (2010) Regulation of MyD88 aggregation and the MyD88-dependent signaling pathway by sequestosome 1 and histone deacetylase 6. J Biol Chem 285: 35759-35769.
40. Serrador JM, Cabrero JR, Sancho D, Mittelbrunn M, Urzainqui A, et al. (2004) HDAC6 deacetylase activity links the tubulin cytoskeleton with immune synapse organization. Immunity 20: 417-428.
41. Brush MH, Guardiola A, Connor JH, Yao TP, Shenolikar S, (2004) Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases. J Biol Chem 279: 7685-7691.
42. Jope RS, Johnson GVW, (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29: 95-102.